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Glycemic and lipidic profiles might be in-
fluenced by several factors. The influence
of the age group in the most extensively
evaluated lipidic and glycemic parameters
is more or less well-accepted. To verify
this empirical notion, 996 human subjects
aged between 21 and 90 years from dif-
ferent localities were characterized accord-
ing to age. To assess lipid profile, total
cholesterol and cholesterol associated with
lipoprotein fractions (low-density lipopro-
tein cholesterol and high-density lipopro-
tein cholesterol) and triglycerides were
determined. Regarding glycemic profile,
glucose, and glycated hemoglobin were
measured. The majority of the population
had values of lipidic parameters fit into the
reference values, presenting low or moder-
ate risk for developing cardiovascular dis-
ease. Blood glucose was often far above
the desirable, but this can be devalued
due to the HbA1c values, which were over-
whelmingly located in the normal range.
The categorization of data in different age
groups did not allow defining statistically
significant differences. Despite the discrim-
inant linear model was presented, the re-
sults indicate that age group did not act
as a strong discriminant factor. Somehow
unexpectedly, the most significant differ-
ences were found among the different lo-
calities, which tended to show a similarity
according with their latitude. Furthermore,
there were no significant correlations in the
parameters associated with lipidic profile,
but there was a direct correlation between
glucose levels and HbA1c (glycemic pa-
rameters). J. Clin. Lab. Anal. 27:237–244,
2013. C© 2013 Wiley Periodicals, Inc.
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INTRODUCTION
The definition of reference values for the main blood
parameters should be as well adapted as possible to the
specific characteristics of a determined population. The li-
pidic components are among the compounds with higher
relevance. The European Systematic Coronary Risk Eval-
uation (SCORE) is the recommended risk estimation sys-
tem and estimates a 10-year risk of cardiovascular (CV)
disease mortality based on age, gender, country of origin,
systolic blood pressure, smoking status, and either total
cholesterol or the total/HDL-c ratio (1).
Lipid guidelines typically focus on total cholesterol ±
low-density lipoprotein cholesterol (LDL-C) levels with
less emphasis on high-density lipoprotein cholesterol
(HDL-C) or triglyceride (TG) assessment, thus poten-
tially underestimating CV risk and the need for lifestyle
or treatment optimization. In current practice, isolated
total cholesterol measurements are frequently used and,
if low, subjects are reassured. However, low total choles-
terol levels may hide HDL-C and TG abnormalities (2).
For instance, multiple statin intervention trials, while con-
firming the benefit of reduction of LDL-C, have demon-
strated an increase in risk associated with low levels of
HDL-C (3). However, early detection of elevated serum
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cholesterol makes possible to identify an important mod-
ifiable risk factor for coronary artery disease (4).
These lipid metabolic changes, commonly known as
dyslipidemias, are caused by disorders in any stage of lipid
metabolism that may cause impact on serum lipoprotein
levels. Occasionally, the genetic defects require the pres-
ence of secondary factors for their clinical expression (dys-
lipidemias of mixed etiology). The majority of primary
dyslipidemias is polygenic, with influence from multiple
genetic and environmental factors (5).
There has also been much debate regarding the role of
elevated TGs in atherosclerosis because of their clear asso-
ciation with vascular risk. High TG might not be directly
associated with CV disease, although they may aggra-
vate disease if subjects have concomitant elevated LDL-C
and/or low HDL-C. Raised TG are also an integral com-
ponent of the insulin resistance syndrome, itself associ-
ated with glucose intolerance, hypertension, and diabetes,
which increases the vascular risk in the presence ofLDL-C
and HDL-C abnormalities (6). On the other hand, main-
taining plasma glucose standard concentrations is crucial
to prevent and/or delay the onset of chronic complica-
tions. Glycated hemoglobin (HbA1c) test is considered as
a benchmark for assessing glycemic control and represents
a summary of glycemic excursions during the 6–8 weeks
prior to its determination (7). This kind of hemoglobin
is extremely useful in diabetes monitoring, providing a
retrospective index of integrated glucose values in plasma
for an extended period (8–10 weeks) (8). In view of these
facts, the characterization of lipidic and glycemic pro-
files assumes particular importance, since it might act as
a fundamental risk assessment evaluator, preventing, or
lowering the occurrence of CV diseases.
Linear discriminant analysis (LDA) is a multivariate
statistical technique whose objectives are: (i) identify
the variables that best distinguish (or discriminate) two
groups of individuals structurally different and mutually
exclusive; (ii) apply these variables to create a discrimi-
nant function that represents parsimoniously the differ-
ences between the groups; and (iii) using this discriminant
function to classify a priori new individuals in the groups.
In this work, the main objective was to evaluate the influ-
ence of age group on lipidic and glycemic profiles, aiming
to understand if the reference values should include po-
tential correction factors defined according with subject’s
age. The influence of locality was also evaluated to check
eventual interaction effects.
MATERIALS AND METHODS
Subjects
Data from 996 subjects (526 females and 470 males)
were obtained in the Clinical Analysis Laboratory Dr.
Matilde Sampaio (Braganc¸aLab, Potugal). The subjects
were resident in the district of Braganc¸a, Northeast of
Portugal, and aged between 21 and 90 years. They were
divided according to age (21–30 years, 17 subjects; 31–
40 years, 38 subjects; 41–50 years, 66 subjects; 51–60
years, 211 subjects; 61–70 years, 309 subjects; 71–80 years,
270 subjects; 81–90 years, 85 subjects) and locality (501
females and 446 males with the following distribution:
Braganc¸a (41◦48′ N; –6◦45′ O), 371 subjects; Alfaˆndega
da Fe´, (41◦20′ N; –6◦59′ O) 261 subjects; Vinhais (41◦50′
N; –7◦00′ O), 192 subjects; Torre de Moncorvo (41◦11′
N; –7◦03′ O), 87 subjects; Miranda do Douro (41◦30′ N;
–6◦16′ O), 36 subjects; the localities/counties with low
number of subjects were removed in this evaluation). In
both cases the ratio males:females was 1.12.
Biological Samples
The analyses were performed in serum (total choles-
terol, LDL-C, HDL-C, TG, and glucose) or whole blood
(HbA1c). Peripheral blood samples were obtained by
venipuncture and placed into polypropylene tubes con-
taining gel for seric determinations or the anticoagulant
EDTA (ethylenediaminetetraacetic acid) for whole blood
parameters. Serum was removed after centrifugation at
1500 g for 10 min at 4◦C.
To assess lipid profile, total cholesterol, LDL-C, HDL-
C, and triglycerides were determined. Regarding the
glycemic profile, glucose, and HbA1c were quantified.
Seric Determinations
To complete this study, several analytical determina-
tions were performed in the serum obtained from blood
samples of users of the Clinical Analysis Laboratory Dr
Matilde Sampaio, Braganc¸aLab, using a COBAS INTE-
GRA 400 plus analyzer (Roche Diagnostics).
Triglycerides quantification
An in vitro test for quantitative determination of the
concentration of triglycerides was carried out in hu-
man serum, using an enzymatic colorimetric assay. This
method is based on Wahlefeld (9) work using a micro-
bial lipoprotein lipase (LPL) for the rapid and complete
hydrolysis of triglycerides [1], followed by phosphorila-
tion to glycerol-3-phosphate catalyzed by glucose kinase
(GK) [2] and oxidation to dihydrocyacetone phosphate
and hydrogen peroxide catalyzed by phosphate oxidase
(GPO) [3]. The hydrogen peroxide then reacts with 4-
aminophenazone (APZ) and 4-chlorophenol (CP), un-
der the catalytic action of peroxidase (POD) to form a
red chromophore (Trinder endpoint reaction) [4]. The
color intensity of the red chromophore was determined at
659 nm, being directly proportional to the concentration
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of triglycerides. As a benchmark, it is recommended a
value below 150 mg/dl (1.7 mmol/l).
triglycerides + 3 H2O LPL−−−→ glycerol + 3RCOOH
(1)
glycerol + ATPGK,Mg
2+
−−−−→ glycerol-3-phosphate + ADP
(2)
glycerol-3-phosphate + O2 GPO−−−→ dihydroxyacetone
phosphate + H2O2 (3)
H2O2 + APZ + CP POD−−−→ 4-(p-benzoquinone
-monoimino)-phenazone
+2H2O + HCl (4)
Total cholesterol quantification
An in vitro test for quantitative determination of the
concentration of cholesterol was carried out in human
serum through an enzyme-based colorimetric assay (9).
Cholesterol esters are cleaved by cholesterol esterase (CE),
producing free cholesterol and fatty acids [5]. Cholesterol
oxidase (CHOD) catalyzes the oxidation of cholesterol
to cholest-4-en-3-one and hydrogen peroxide [6]. In the
presence of POD, hydrogen peroxide affects the oxida-
tive coupling of phenol and 4-aminoantipyrine (AAP),
forming a red quinone-imine chromophore [7]. The color
intensity was determined measuring the absorbance at
512 nm, being directly proportional to the concentra-
tion of cholesterol. The levels for adults in terms of
risk or coronary heart disease are: recommended: <200
mg/dl (5.2 mmol/l); moderate risk: 200–239 mg/dl (5.2–
6.2 mmol/l); high risk: ≥240 mg/dl (≥6.2 mmol/l).
cholesterol esters + H2O CE−−−→ cholesterol + 3RCOOH
(5)
cholesterol + O2 CHOD−−−→ cholest-4-en-3-one + H2O2
(6)
2H2O2 + 4-AAP + phenol POD−−−→ quinone-imino
chromophore + 4H2O (7)
HDL-C quantification
An in vitro test for quantitative determination of the
concentration of HDL-c was carried out in human serum
using a homogeneous enzyme-based colorimetric assay
(9). In the presence of magnesium ions and dextran sul-
fate, water-soluble complexes with LDL, VLDL, and chy-
lomicrons are formed, being resistant to enzymes modi-
fied by polyethylene glycol (PEG). The concentration of
HDL-C is determined enzymatically by CE and CHOD
coupled with amino groups (40%). CE quantitatively de-
composes cholesterol esters into free cholesterol and fatty
acids [8]. In the presence of oxygen, cholesterol is oxidized
by CHOD to4-cholestenone and hydrogen peroxide [9].
The intensity of the violet quinone-imine chromophore
[10], directly proportional to the concentration of HDL-
C, was determined by measuring the absorbance at
583 nm.
Considering the risk of coronary heart disease, the
recommended levels for adults are: recommended: >60
mg/dl (>1.55 mmol/l); moderate risk: 40–60 mg/dl
(1.04–1.55 mmol/l); high risk: <40 mg/dl (<1.04
mmol/l).
HDL-C esters + H2O PEG−cholestrol esterase−−−−−−−−−−−−→HDL-C
+RCOOH (8)
HDL-C + O2 PEG−cholestrol oxidase−−−−−−−−−−−−→4-cholestenone
+H2O2 (9)
2H2O2 + 4-AAP + HSDA POD−−−→ quinone-imino
chromophore + 5H2O (10)
aN-(2-hydroxy-3-sulfopropyl)-3,5-dimethoxyaniline
sodium
LDL-C quantification
LDL-C contents were obtained from measurements of
total cholesterol, triglycerides, and HDL-C by the Friede-
wald approximation:
LDL-C = total cholesterol-HDL-C-tryglycerides
5
This calculation is valid for concentrations of triglyc-
erides under 400mg/dl (4.52mmol/l). The recommended
levels for adults, regarding coronary heart disease risk are:
Desirable: <130 mg/dl; moderate risk: 130–159 mg/dl;
high risk: >160 mg/dl.
Glucose quantification
An in vitro test for quantitative determination of the
concentration of glucose concentration was carried out
in human serum by a colorimetric assay with hexokinase
(HK) enzymatic reference (9). HK catalyzes the phospho-
rylation of glucose by ATP, yielding glucose-6-phosphate
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and ADP [11]. To continue the reaction, a second en-
zyme, glucose-6-phosphate dehydrogenase (G6PDH) is
used to catalyze the oxidation of glucose-6-phosphate by
NADP+, leading to NADPH [12]. The concentration of
NADPH formed is directly proportional to the concen-
tration of glucose and was determined by measuring the
absorbance at 340 nm. The reference values lay among 70
and 110 mg/dl (3.89 and 6.11 mmol/l).
D-glucose + ATP HK−−−→D-glucose-6-fosfato + ADP
(11)
D-glucose-6-fosfato + NADP + G6PDH−−−→D-fosfogluconato
+NADPH + H+(12)
Whole Blood Determinations
HbA1c quantification
HbA1c was determined with an analyzer HA-1840 (A.
Menarini Diagnostics), which uses reversed-phase ionic
change high performance liquid chromatography (10).
The fractions are separated by electrostatic interactions
with the gel column, whose surface contains hydropho-
bic groups and ion exchange groups. The signal of the
separated hemoglobin fractions was red at two distinct
wavelengths: HgA1 fraction at 415 nm and HbF fraction
at 500 nm.The reference values for this analyte are 4.5–7%
for healthy subjects or patients with controlled diabetes;
7–8.5% for patients with inadequate treatment or subclin-
ical diabetes with normal glucose value but with altered
tolerance test; > 8.5% for diabetics without control.
Statistical Analysis
Ananalysis of variance (ANOVA)withType III sums of
squares was performed using the General Linear Model
(GLM) procedure of the SPSS software, version 18.0
(SPSS, Inc.). All dependent variables were analyzed using
a 2-way ANOVA, being the main factors the “age group”
(21–30, 31–40, 41–50, 51–60, 61–70, 71–80, and 81–
90 years) and the “locality” (Alfaˆndega da Fe´, Braganc¸a,
Macedo de Cavaleiros, Torre de Moncorvo, Vinhais) of
the tested subjects. The assumption of equal variances
among groups (homoscedastic distribution) was tested
through Levene’s test, with further application of Tukey
honestly significant difference (HSD), α = 0.05. Tukey
HSD uses the Studentized range statistic to make all pair-
wise comparisons between groups and sets the experiment
wise error rate to the error rate for the collection for all
pairwise comparisons. In addition, a LDA was used as a
technique to classify the seven age groups as well as the
five localities according to their lipidic and glycemic seric
profiles. A stepwise technique, using theWilks’  method
with the usual probabilities of F, was applied for variable
selection. It is fundamental to test the ability of discrim-
inant functions to significantly discriminate the groups.
Hence, it is intended to test if the group centroids (this is,
the mean of all discriminant functions for each group) are
equal or if there is at least a different one. This procedure
uses a combination of forward selection and backward
elimination procedures, where the selection of each new
variable is preceded by the verification of the significance
of all the previously selected variables (11, 13). With this
approach, it is possible to identify the significant variables
among the lipidic and glycemic parameters obtained for
each sample. To verify which canonical discriminant func-
tions were significant, theWilks’ test was applied. TheF
value for eachWilks’  value resulting from the inclusion
or removal of a variable is calculated as follows:
F =
(
n-g-p
g-1
)⎛⎝1-
λp+1
λp
λp+1
λp
⎞
⎠
where n is sample global dimension, g is the number of
groups, p is the number of independent variables, λp is
the Wilks’  value prior to the inclusion/removal of the
new variable and λp + 1 is the Wilks’  value after the
inclusion/rejection of the new variable. This statistic fol-
lows F-Snedecor distribution with (g – 1) and (n – g – p)
degrees of freedom, and the associated significance prob-
ability measures the significance of the inclusion/removal
of the new variable. To avoid overoptimistic data modu-
lation, a leaving-one-out cross-validation procedure was
carried out to assess the model performance. The LDA
statistical analysis and the other statistical tests were per-
formed at a 5% significance level using the SPSS software
mentioned above.
RESULTS
Prior to the statistical interpretation of results, the main
outcomes will be described in order to characterize the
studied population. All the results are presented consid-
ering different age groups (Table 1) and localities (Table 2)
as the mean value of each age group (Table 1) or locality
(Table 2) independently of gender (G), as well as the mean
for each gender for all age groups (A) or localities (L). In
this way, the results allow a more comprehensive analysis
of the influence exerted by each one of the main factors
under study, avoiding interaction effects. Nevertheless, re-
sults showed that the interaction A × G acted as a sig-
nificant source of variation (P < 0.05) only for glucose
(P= 0.043) and HbA1c (P= 0.043), while the interaction
L×Gdid not exerted this effect in any case.Regarding the
results found in eachmain factor, the differenceswere only
statistically significant for locality influence, in the cases
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TABLE 1. Biochemical Parameters (mg/dl) in Function of the Assayed Age Groups (A). The Results are Expressed as Mean ± SD
(n = 996; 470 Males and 526 Females)
Total cholesterol HDL-c LDL-c Triglycerides Glucose HbA1c (%)
Age (A) 21–30 202 ± 34 50 ± 8 129 ± 31 117 ± 60 100 ± 36 5 ± 1
31–40 188 ± 44 47 ± 7 112 ± 37 142 ± 61 134 ± 68 6 ± 2
41–50 207 ± 45 49 ± 11 130 ± 37 141 ± 63 139 ± 70 7 ± 2
51–60 204 ± 46 47 ± 8 126 ± 43 156 ± 76 133 ± 60 6 ± 2
61–70 197 ± 42 47 ± 9 122 ± 39 137 ± 64 134 ± 52 7 ± 2
71–80 200 ± 46 47 ± 8 125 ± 41 144 ± 66 131 ± 57 7 ± 2
81–90 200 ± 39 48 ± 9 124 ± 34 137 ± 60 121 ± 47 6 ± 2
P-value 0.226 0.371 0.379 0.069 0.076 0.094
Gender (G) Male 197 ± 44 46 ± 9 122 ± 40 145 ± 73 132 ± 58 6 ± 2
Female 202 ± 44 48 ± 8 126 ± 39 141 ± 61 132 ± 55 7 ± 2
P-value 0.357 0.274 0.375 0.785 0.594 0.636
A × G P-value 0.454 0.449 0.412 0.558 0.043 0.036
of total cholesterol, HDL-C, glucose, and and HbA1c;
therefore, multiple comparisons were only performed
in these situations (Table 2). However, some general
observations could be pointed out for the remaining
cases by analyzing the estimated marginal means (EMM)
plots.
The subjects belonging to 41–50 years age group (A)
registered the highest total cholesterol (207 ± 45 mg/dl)
and LDL-C (130 ± 37 mg/dl), while the lowest values
of these parameters were obtained in the 31–40 years A
(Table 1). HDL-C seemed to be less related with total
cholesterol, since its highest value (50 ± 10 mg/dl) was
detected for the 21–30 years A. Regarding triglycerides,
the highest value (156 ± 76 mg/dl) was found for subjects
with ages varying from 51 to 60 years, while the lowest
(117 ± 30 mg/dl) was registered for the 21–30 years A.
Glucose (100 ± 36 mg/dl) and HbA1c (5 ± 1%) reached
minimal values in the 21–30 years A.
Despite no statistical differences could be found for
the assayed A, it is noteworthy that the parameters with
potential negative effect for the coronary heart diseases
reachedmaximal values in the 41–50A, since younger sub-
jects remain, in general, physiologically protected, while
older ones are probably under some therapeutic follow up.
Concerning locality (L) influence (Table 2), the high-
est total cholesterol value was obtained in Alfaˆndega da
Fe´ (206 ± 45 mg/dl) and Torre de Moncorvo (206 ±
54 mg/dl), while the lowest was registered in Miranda do
Douro (187 ± 28 mg/dl).
TheHDL-C fraction did not vary greatly, while LDL-C
exhibited a noticeable variation, with maximum values in
Alfaˆndega da Fe´ (129 ± 40 mg/dl) and Torre de Mon-
corvo (130 ± 46 mg/dl) and lowest values in Miranda do
Douro (113 ± 28 mg/dl), showing again a close associa-
tion with total cholesterol content.
The triglycerides profiles denoted high similarity; how-
ever, a tendency to higher values could be observed in
Vinhais (148 ± 62 mg/dl), while the lowest values tended
to be obtained in Miranda do Douro (131 ± 65 mg/dl).
The glycemic parameters showed significant differences,
with maximal values of glucose in Vinhais (143 ± 59
mg/dl) and minimal values in Torre de Moncorvo (110 ±
33 mg/dl); HbA1c was also higher in Vinhais, as well as
in Miranda do Douro (7 ± 2% in both localities), while
TABLE 2. Biochemical Parameters (mg/dl) in Function of the Selected Localities (L). The Results are Expressed as Mean ± SD
(n = 947; 446 Males and 501 Females). In Each Column and for Each Parameter, Different Letters Mean Significant (P < 0.05)
Differences
Total cholesterol HDL-c LDL-c Triglycerides Glucose HbA1c (%)
Locality (L) Alfaˆndega da Fe´ 206 ± 45 a 48 ± 10 129 ± 40 a 144 ± 73 121 ± 53 bc 6 ± 2 b
Braganc¸a 198 ± 42 ab 47 ± 8 122 ± 39 ab 142 ± 68 133 ± 58 ab 6 ± 2 ab
Miranda do Douro 187 ± 28 b 48 ± 8 113 ± 28 b 131 ± 65 140 ± 50 ab 7 ± 2 a
Torre de Moncorvo 206 ± 54 a 48 ± 10 130 ± 46 a 143 ± 65 110 ± 33 c 6 ± 1 b
Vinhais 195 ± 45 ab 46 ± 7 120 ± 40 ab 148 ± 62 143 ± 59 a 7 ± 2 a
P-value 0.012 0.068 0.016 0.718 <0.001 <0.001
Gender (G) Male 197 ± 44 46 ± 9 122 ± 40 146 ± 73 130 ± 57 6 ± 2
Female 203 ± 45 48 ± 8 126 ± 40 142 ± 62 130 ± 55 6 ± 2
P-value 0.100 0.060 0.155 0.956 0.886 0.326
L × G P-value 0.913 0.764 0.924 0.789 0.986 0.525
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the lowest values were registered in Torre de Moncorvo
and Alfaˆndega da Fe´ (Table 2).
DISCUSSION
In general, the different age groups revealed higher
homogeneity for all the assayed parameters, when com-
pared with the locality influence. It should be pointed
out that when the Tukey’s classification could be applied,
Braganc¸a and Vinhais, two localities with geographical
proximity, were equally classified in almost all cases, being
observed a very similar outcome for Torre de Moncorvo
and Alfaˆndega da Fe´, that are also very close to each
other.
Regarding the effect induced by gender, the results
did not reveal statistically significant differences among
men and women. Nevertheless, the assayed female sub-
jects tended to have higher total cholesterol, HDL-C, and
LDL-C values, whilemale subjects leaned to presentmore
elevated glucose levels.
For the cases in which the multiple comparisons could
not be performed, the EMM plots (data not shown) con-
firmed the previously described tendencies, either con-
cerning A or L influence.
Furthermore, most of the subjects had total cholesterol
values ranging from 150 to 240 mg/dl, with results vary-
ing from 100 to 388 mg/dl. Considering reference values,
the majority of population is located under the recom-
mended value (<200mg/dl) or moderate risk range (200–
239 mg/dl), with only a small proportion of subjects with
high risk (>240 mg/dl) of coronary artery disease. Re-
garding HDL-C, most subjects had results varying from
35 to 60 mg/dl, with a high number of subjects located
on the moderate risk range (35–55 mg/dl), despite results
varied from 26 to 105 mg/dl.
Concerning LDL-C, the obtained results varied from
17 to 290 mg/dl, with a major proportion concentrated
between 70 and 150 mg/dl. It is noteworthy that only a
small part of the population-presented values classified as
high risk (>160 mg/dl) for coronary heart disease, while
most subjects presented desirable values (<130 mg/dl).
Triglycerides ranged from 42 to 395 mg/dl, with an el-
evated number of subjects presenting values in the 50–
200mg/dl range; the majority of population presented, in
fact, a good result with concentrations under 150 mg/dl.
However, there is also a considerable number of subjects
in the high-risk range.
Regarding glycemic parameters, glucose varied from 65
to 405 mg/dl, with most subjects located in the 80–180
mg/dl range, a concerning result since the desirable val-
ues should not be higher than 110 mg/dl. In the case of
HbA1c, the obtained results varied from 3.7 to 14.3%,
with most subjects concentrated in the 4–8.5% range, re-
specting the adequate reference standard (7–8.5%), an im-
portant finding since HbA1c is the most adequate test for
quantification of cronic complications hazzard in diabetes
patients (14).
In order to understand if the studied parameters (con-
tinuous variables) were correlated, their frequency distri-
bution was analyzed using a 3D density plot. These cor-
relations were tested with at least one of the parameters
presenting values out of the reference values, since this
could act as a more reliable disease indicator. In none of
the cases (one or both parameters out of reference val-
ues) it was found a good correlation among HDL-C and
triglycerides, LDL-C and triglycerides, or LDL-C and to-
tal cholesterol. The only parameters that proved to be
strongly correlated were glucose and HbA1c, either with
one (Fig. 1A) or both (Fig. 1B) biochemical parameters
outside of the reference limits.
Regarding the main objective of this work, the differ-
ences induced by A were evaluated by stepwise LDA,
resulting in a discriminant model with three significant
functions (P < 0.05 for Wilks’  test) (Fig. 2). Concern-
ing A (Fig. 2A), the three functions explained 100.0% of
the observed variance, with the first function responsible
for 52.09%, the second 28.75%, and the third 19.16%. The
discriminant power proportion of the nth function may
be estimated by the ratio among its own value and the
sum of all discriminant functions values. The canonical
discriminant function coefficients allowed obtaining the
following model:
Function 1: D1 = 0.005 × triglycerides + 0.028
× glucose-1.028 × HbA1c + 2.225;
Function 2: D2 = 0.012 × triglycerides − 0.001
× glucose + 0.281 × HbA1c − 3.361;
Function 3: D3 = −0.009 × triglycerides + 0.020
× glucose − 0.094 × HbA1c − 0.722.
Regarding classification function coefficients, the fol-
lowing functions were obtained:
[21-30] c1 = 0.019 × triglycerides-0.042 × glucose
+ 2.473 × HbA1c-7.108;
[31-40] c2 = 0.022 × triglycerides − 0.046 × glucose
+ 2.977 × HbA1c − 9.907;
[41-50] c3 = 0.021 × triglycerides − 0.049 × glucose
+ 3.154 × HbA1c − 10.495;
[51-60] c4 = 0.025 × triglycerides − 0.049 × glucose
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Fig. 1. 3D density graph plotting of glucose and HbA1c frequency
distributions. (A) One of the parameters outside the reference limits; (B)
both parameters outside the reference limits.
+ 3.015 × HbA1c − 10.307;
[61-70] c5 = 0.021 × triglycerides − 0.051 × glucose
+ 3.149 × HbA1c − 10.231;
[71-80] c6 = 0.023 × triglycerides − 0.055 × glucose
+ 3.268 × HbA1c − 10.628;
[81-90] c7 = 0.021 × triglycerides − 0.064 × glucose
+ 3.491 × HbA1c − 10.767.
Fig. 2. Canonical analysis of age group (A) and locality (B) influence
based on the biochemical assayed parameters.
However, the defined functions were not able to sepa-
rate the results in individualized groups, confirming the
already detected similarity among the obtained results.
In fact, the selected variables did not show discriminant
ability, as the classification performance indicated, with
only 14.4% of the original groups and 13.3% of the cross-
validated groups being correctly classified.
Regarding L influence (Fig. 2B), the three defined
functions included 100.0% of the observed variance, dis-
tributed as 87.48% for the first, 10.64 for the second and
J. Clin. Lab. Anal.
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1.88 for the third function. The classification function co-
efficients resulted in the following model:
Function 1:D1 = −0.013 × cholesterol + 0.010
× glucose + 0.212 × HbA1c − 0.119;
Function 2:D2 = 0.001 × cholesterol + 0.033
× glucose − 1.033 × HbA1c + 1.980;
Function 3:D3 = 0.019 × triglycerides + 1E−5
× glucose + 0.280 × HbA1c − 5.548.
However, and despite the found significant differences,
the model was not able to separate the results in indi-
vidual clusters corresponding to the five naturally occur-
ring groups. In terms of classification ability, the results
were again unsatisfactory, since only 8.9% of the origi-
nal groups and 17.8% of the cross validates groups were
correctly classified. Nevertheless, since the classification
performance was slightly higher than the obtained for the
age group influence, the classification function coefficients
are also presented:
Alf aˆndega daFe´ c1 = 0.103 × cholesterol-0.067
× glucose + 3.584 × HbA1c
− 19.129;
Braganc¸a c2 = 0.099 × triglycerides-0.062
× glucose + 3.547 × HbA1c
− 18.684;
Miranda doDouro c3 = 0.093 × triglycerides-0.070
× glucose + 3.942 × HbA1c
− 19.142;
Torre deMoncorvo c4 = 0.104 × triglycerides-0.073
× glucose + 3.646 × HbA1c
− 19.077;
Vinhais c5 = 0.097 × triglycerides-0.064
× glucose + 3.746 × HbA1c
− 19.373.
CONCLUSION
In general, the results proved to have higher similarity
according with age group than with locality. This seems
to indicate that the blood parameters references values
exempt the inclusion of any age correction factors, since
the obtained values exhibit close amplitude and magni-
tude. Actually, this is also reflected in the similarity of
the obtained coefficients, either for the canonical discrim-
inant function, or for the classification function. This
study revealed that, although the studied localities are
relatively close, the results obtained for the assayed bio-
chemical parameters revealed statistically significant dif-
ferences. Surprisingly, this influence surpassed the effect
of age group, but deeper conclusions could only be ob-
tained with additional analysis, like specific diet or use of
cholesterol control therapeutic agents. Nevertheless, this
work contributed to a more comprehensive knowledge of
lipidic and glycemic indexes among the assayed popula-
tion. Future works should be oriented to establish corre-
lation among these blood profiles and the emergence or
development of some common metabolic diseases, allow-
ing defining reliable biomarkers and helpful prevention
strategies.
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